PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Feb-2025 Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status AccessWire
12-Feb-2025 Oral Care Market (2024-2035): Industry Insights, Trends, and Future Outlook Vantage Market Research
12-Feb-2025 CTT Pharma Gives Update On NSF Grant AccessWire
12-Feb-2025 Genomics in Cancer Care Market: Trends, Innovations, and Future Outlook (2024-2035) Vantage Market Research
12-Feb-2025 Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters AccessWire
12-Feb-2025 Biolog Purchases Anaerobe Systems, Its Third Acquisition, Becoming the Knowledge Leader in Microbiology Research and Clinical Sample Prep AccessWire
12-Feb-2025 Agentic AI in Healthcare: Trends, Market Demand, and Future Innovations Medi-Tech Insights
11-Feb-2025 JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform JuliaHub
11-Feb-2025 The 7th CKD Drug Development Summit Returns to Boston to Shape the Future of Renal Therapeutics Hanson Wade
11-Feb-2025 Early Detection Of Breast Cancer Seen As A Benefit With Seated Option in the VELA Mammography Chair, Enable Me Finds in Technologist Survey AccessWire
11-Feb-2025 CAR T-Cell Therapy Market Size & Trends | 2025–2035 Vantage Market Research
11-Feb-2025 Aston Institute for Membrane Excellence wins £13.2m of UK government and co-funding for water treatment technology Aston Institute for Membrane Excellence
11-Feb-2025 LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND TO TREAT GERMLINE BRCA-MUTATED HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER CHEMOTHERAPY AstraZeneca
11-Feb-2025 ELLIPSES IN-LICENCES FIRST IN CLASS NOVEL IMMUNO-ONCOLOGY AGENT WITH POTENTIAL AS A NEXT GENERATION CHECKPOINT INHIBITOR Ellipses Pharma Limited
11-Feb-2025 ENA Respiratory Receives US$5m Investment from Flu Lab to Support Clinical Development of Novel Intranasal Antiviral Host Defence Immune Enhancer, INNA-051 ENA Respiratory
11-Feb-2025 Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month Mainz BioMed N.V.
11-Feb-2025 Resurgens Orthopaedics Promotes Transparently Priced Musculoskeletal Care Through New Partnership With HealthMe AccessWire
11-Feb-2025 Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH) Sernova Biotherapeutics Inc
11-Feb-2025 vVARDIS Announces $35 Million Financing with Global Healthcare Investor OrbiMed to Roll Out Curodont, an Innovative Drill-Free Treatment for Early Tooth Decay AccessWire
11-Feb-2025 Pioneer and Novo Nordisk crown Melio Bio winner of 2025 Golden Ticket Programme Pioneer Group